Linezolid Therapy of Vancomycin-Resistant Enterococcus faecium Experimental Endocarditis

We compared the activities of linezolid (25 mg/kg of body weight, administered intraperitoneally every 8 h) and of vancomycin (25 mg/kg of body weight, administered intraperitoneally every 8 h) in a rat model of vanA vancomycin-resistant Enterococcus faecium experimental endocarditis. Results were e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Patel, Robin, Rouse, Mark S., Piper, Kerryl E., Steckelberg, James M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2001
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC90339/
https://ncbi.nlm.nih.gov/pubmed/11158767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.2.621-623.2001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia